Cleared Traditional

K792436 - VXTRA BACK PACK EKG ELECTRODE CAT. NO.

K792436 is an FDA 510(k) clearance for VXTRA BACK PACK EKG ELECTRODE CAT. NO., manufactured by Vxtra Corp.. The device is a Class 2 Cardiovascular device with product code DRX cleared through the Traditional 510(k) pathway after a 86-day FDA review.

Download Printable Device Report (PDF)
Optimized for regulatory review, auditing and printing
Feb 1980
Decision
86d
Days
Class 2
Risk

K792436 is an FDA 510(k) clearance for the VXTRA BACK PACK EKG ELECTRODE CAT. NO.. Classified as Electrode, Electrocardiograph (product code DRX), Class II - Special Controls.

Submitted by Vxtra Corp. (Mchenry, US). The FDA issued a Cleared decision on February 22, 1980 after a review of 86 days - a notably fast clearance cycle.

This device falls under the Cardiovascular FDA review panel, regulated under 21 CFR 870.2360 - the FDA cardiovascular device oversight framework. The Traditional 510(k) pathway establishes clearance through substantial equivalence to a legally marketed predicate device, without requiring clinical trial data.

Device pattern: Fast-track predicate clearance. Standard predicate reliance. The short review cycle indicates strong predicate alignment - the FDA found sufficient equivalence without extended technical review.

FDA 510(k) Submission Details - K792436

510(k) Number K792436 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received November 28, 1979
Decision Date February 22, 1980
Days to Decision 86 days
Submission Type Traditional
Review Panel Cardiovascular (CV)
Summary -
Third-party Review No - reviewed directly by FDA
Regulatory Context
Review time vs. panel average
39d faster than avg
Panel avg: 125d · This submission: 86d
Pathway characteristics
Predicate-based equivalence. No clinical trials required.

DRX Device Classification - Class 2, Special Controls

Product Code DRX Electrode, Electrocardiograph
Device Class Class 2 - Special Controls
CFR Regulation 21 CFR 870.2360
What this classification means

Class II devices require demonstration of substantial equivalence to a legally marketed predicate device. This pathway does not require clinical trials - it relies on engineering equivalence and performance data. Most Cardiovascular devices follow this clearance model.

Regulatory Peers - DRX Electrode, Electrocardiograph

All 328
Devices cleared under the same product code (DRX) and FDA review panel - the closest regulatory comparables to K792436.
R2(TM) ECG ELECTRODE SET-#'S305-306 ETC.
K800930 · R2 Corp. · May 1980
R2 APEX-POST.,ANT.&POST. ELECT.(12 MODS)
K800935 · R2 Corp. · May 1980
ESOPHAGEAL PILL-ELECTRODE
K800201 · Arzbaecher & Co. · Feb 1980
BARD BIOMEDICAL PRINTED SILVER ELECTRODE
K792040 · C.R. Bard, Inc. · Nov 1979
PREGELLED DISPOSABLE ECG ELECTRODES
K791139 · Hayes Products, Inc. · Jul 1979
PREGELLED DISPOSABLE EELCTRO. SERIES 600
K791140 · Hayes Products, Inc. · Jul 1979